Alamar Biosciences (ALMR) vs Cytek Biosciences (CTKB)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Alamar Biosciences is the larger company by market cap ($1.80 billion vs $696.7 million), about 2.6 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ALMR | CTKB |
|---|---|---|
| Share price | $25.91 | $5.36 |
| Market cap | $1.80B | $696.71M |
| 1-day change | -6.70% | +0.37% |
| YTD return | — | +5.74% |
| 1-year return | — | +40.90% |
| 5-year return | — | -77.81% |
| Forward P/E | — | 76.57 |
| EPS (TTM) | $-1.20 | $-0.62 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $39.61 | $6.21 |
| 52-week low | $18.85 | $3.31 |
| Distance from 52-week high | -34.59% | -13.69% |
| Analyst consensus | buy | none |
| Avg. price target upside | +36.63% | +3.73% |
| Average volume | 399.23K | 1.04M |
| Shares outstanding | 69.39M | 129.98M |
| Employees | 286 | 682 |
| Sector | Industrials | Industrials |
| Industry | Biotechnology: Laboratory Analytical Instruments | Biotechnology: Laboratory Analytical Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Alamar Biosciences is about 2.6 times larger than Cytek Biosciences by market value ($1.80B vs $696.71M).
About Alamar Biosciences
ALMR stock →Alamar Biosciences, Inc., a proteomics company, develops a proteomic liquid biopsy platform and sells instruments, consumables, and services to early detection of diseases. The company develops NULISA technology, a proteomics platform that detects and quantifies protein biomarkers.
Industrials · Biotechnology: Laboratory Analytical Instruments · 286 employees
About Cytek Biosciences
CTKB stock →Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitate scientific advances in biomedical research and clinical applications. The company offers Cytek aurora, northern lights systems, and Cytek aurora evo systems delivers cell analysis; Cytek Aurora CS System, a cellular complexity to perform additional downstream genomic and proteomic studies using phenotyping approaches; enhanced small particle detection; Cytek amnis imagestream imaging flow cytometers; Cytek guava muse cell analyzers; Cytek muse micro cell analyzers; Cytek guava easyCyte flow cytometers; and Cytek orion reagent cocktail preparation systems.
Industrials · Biotechnology: Laboratory Analytical Instruments · 682 employees
ALMR vs CTKB FAQ
Which is bigger, Alamar Biosciences or Cytek Biosciences?
Alamar Biosciences (ALMR) is larger, with a market capitalization of $1.80B compared with $696.71M for Cytek Biosciences (CTKB).
Are Alamar Biosciences and Cytek Biosciences in the same industry?
Yes. Both are classified in the Biotechnology: Laboratory Analytical Instruments industry within the Industrials sector.